2018-2023 Global Point-of-care Infectious Disease Diagnostics Market Report (Status and Outlook)
![](/report_cover/10189/2018-2023-global-point-of-care-infectious-disease-diagnostics-market-report-status-n-outlook_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Point-of-care Infectious Disease Diagnostics market for 2018-2023.
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
Over the next five years, LPI(LP Information) projects that Point-of-care Infectious Disease Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Point-of-care Infectious Disease Diagnostics market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Point-of-care Infectious Disease Diagnostics market for 2018-2023.
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
Over the next five years, LPI(LP Information) projects that Point-of-care Infectious Disease Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Point-of-care Infectious Disease Diagnostics market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
- HIV POC
- Clostridium Difficile POC
- Respiratory Syncytial Virus POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB and Drug-Resistant TB POC
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Alere
- Calypte Biomedical
- Chembio Diagnostic Systems
- Meridian Bioscience
- MedMira
- Trinity Biotech
- Sekisui Diagnostics
- OraSure Technologies
- Quidel
Research objectives
- To study and analyze the global Point-of-care Infectious Disease Diagnostics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Point-of-care Infectious Disease Diagnostics market by identifying its various subsegments.
- Focuses on the key global Point-of-care Infectious Disease Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Point-of-care Infectious Disease Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the size of Point-of-care Infectious Disease Diagnostics submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size 2013-2023
2.1.2 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region
2.2 Point-of-care Infectious Disease Diagnostics Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium Difficile POC
2.2.3 HBV POC
2.2.4 Respiratory Syncytial Virus POC
2.2.5 HPV POC
2.2.6 Influenza/Flu POC
2.2.7 HCV POC
2.2.8 MRSA POC
2.2.9 TB and Drug-Resistant TB POC
2.3 Point-of-care Infectious Disease Diagnostics Market Size by Type
2.3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2013-2018)
2.3.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (2013-2018)
2.4 Point-of-care Infectious Disease Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-care Infectious Disease Diagnostics Market Size by Application
2.5.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2013-2018)
2.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application (2013-2018)
3 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY PLAYERS
3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Players (2016-2018)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players (2016-2018)
3.2 Global Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY REGIONS
4.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions
4.2 Americas Point-of-care Infectious Disease Diagnostics Market Size Growth
4.3 APAC Point-of-care Infectious Disease Diagnostics Market Size Growth
4.4 Europe Point-of-care Infectious Disease Diagnostics Market Size Growth
4.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth
5 AMERICAS
5.1 Americas Point-of-care Infectious Disease Diagnostics Market Size by Countries
5.2 Americas Point-of-care Infectious Disease Diagnostics Market Size by Type
5.3 Americas Point-of-care Infectious Disease Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Point-of-care Infectious Disease Diagnostics Market Size by Countries
6.2 APAC Point-of-care Infectious Disease Diagnostics Market Size by Type
6.3 APAC Point-of-care Infectious Disease Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Point-of-care Infectious Disease Diagnostics by Countries
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics by Countries
8.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type
8.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast (2018-2023)
10.2 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions
10.2.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Point-of-care Infectious Disease Diagnostics Forecast by Type
10.8 Global Point-of-care Infectious Disease Diagnostics Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Company Details
11.1.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Thermo Fisher Scientific News
11.2 Alere
11.2.1 Company Details
11.2.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.2.3 Alere Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Alere News
11.3 Calypte Biomedical
11.3.1 Company Details
11.3.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Calypte Biomedical News
11.4 Chembio Diagnostic Systems
11.4.1 Company Details
11.4.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Chembio Diagnostic Systems News
11.5 Meridian Bioscience
11.5.1 Company Details
11.5.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Meridian Bioscience News
11.6 MedMira
11.6.1 Company Details
11.6.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 MedMira News
11.7 Trinity Biotech
11.7.1 Company Details
11.7.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Trinity Biotech News
11.8 Sekisui Diagnostics
11.8.1 Company Details
11.8.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Sekisui Diagnostics News
11.9 OraSure Technologies
11.9.1 Company Details
11.9.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 OraSure Technologies News
11.10 Quidel
11.10.1 Company Details
11.10.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Quidel News
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size 2013-2023
2.1.2 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region
2.2 Point-of-care Infectious Disease Diagnostics Segment by Type
2.2.1 HIV POC
2.2.2 Clostridium Difficile POC
2.2.3 HBV POC
2.2.4 Respiratory Syncytial Virus POC
2.2.5 HPV POC
2.2.6 Influenza/Flu POC
2.2.7 HCV POC
2.2.8 MRSA POC
2.2.9 TB and Drug-Resistant TB POC
2.3 Point-of-care Infectious Disease Diagnostics Market Size by Type
2.3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2013-2018)
2.3.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (2013-2018)
2.4 Point-of-care Infectious Disease Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Home
2.4.4 Assisted Living Healthcare Facilities
2.4.5 Laboratories
2.4.6 Others
2.5 Point-of-care Infectious Disease Diagnostics Market Size by Application
2.5.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2013-2018)
2.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application (2013-2018)
3 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY PLAYERS
3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Players (2016-2018)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players (2016-2018)
3.2 Global Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS BY REGIONS
4.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions
4.2 Americas Point-of-care Infectious Disease Diagnostics Market Size Growth
4.3 APAC Point-of-care Infectious Disease Diagnostics Market Size Growth
4.4 Europe Point-of-care Infectious Disease Diagnostics Market Size Growth
4.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth
5 AMERICAS
5.1 Americas Point-of-care Infectious Disease Diagnostics Market Size by Countries
5.2 Americas Point-of-care Infectious Disease Diagnostics Market Size by Type
5.3 Americas Point-of-care Infectious Disease Diagnostics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Point-of-care Infectious Disease Diagnostics Market Size by Countries
6.2 APAC Point-of-care Infectious Disease Diagnostics Market Size by Type
6.3 APAC Point-of-care Infectious Disease Diagnostics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Point-of-care Infectious Disease Diagnostics by Countries
7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics by Countries
8.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type
8.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 GLOBAL POINT-OF-CARE INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST
10.1 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast (2018-2023)
10.2 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions
10.2.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Point-of-care Infectious Disease Diagnostics Forecast by Type
10.8 Global Point-of-care Infectious Disease Diagnostics Forecast by Application
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Company Details
11.1.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Thermo Fisher Scientific News
11.2 Alere
11.2.1 Company Details
11.2.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.2.3 Alere Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Alere News
11.3 Calypte Biomedical
11.3.1 Company Details
11.3.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Calypte Biomedical News
11.4 Chembio Diagnostic Systems
11.4.1 Company Details
11.4.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Chembio Diagnostic Systems News
11.5 Meridian Bioscience
11.5.1 Company Details
11.5.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Meridian Bioscience News
11.6 MedMira
11.6.1 Company Details
11.6.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 MedMira News
11.7 Trinity Biotech
11.7.1 Company Details
11.7.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Trinity Biotech News
11.8 Sekisui Diagnostics
11.8.1 Company Details
11.8.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Sekisui Diagnostics News
11.9 OraSure Technologies
11.9.1 Company Details
11.9.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 OraSure Technologies News
11.10 Quidel
11.10.1 Company Details
11.10.2 Point-of-care Infectious Disease Diagnostics Product Offered
11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Quidel News
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Table Product Specifications of Point-of-care Infectious Disease Diagnostics
Figure Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure Market Research Methodology
Figure
Table Product Specifications of Point-of-care Infectious Disease Diagnostics
Figure Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure Market Research Methodology
Figure